Not even a terrible finish to the month could stop the S&P/ASX 200 Index (ASX: XJO) from pushing higher in October. The benchmark index gained 1.9% to finish at 5,927.6 points.
Not all shares were able to climb higher with the market today. Here’s why these were the worst performers on the ASX 200 in October:
Iluka Resources Limited (ASX: ILU)
The Iluka Resources share price was the worst performer on the ASX 200 in October with a 43.5% decline. However, this decline was nothing to do with the performance of the mineral sands company. It was due to the spin-off of its Deterra Royalties Ltd (ASX: DRR) business. Eligible shareholders received 1 Deterra Royalties share for every Iluka share they owned.
Mesoblast limited (ASX: MSB)
The Mesoblast share price wasn’t far behind and crashed 39.8% lower last month. This disappointing decline came after the biotechnology company revealed that the US FDA has not approved its remestemcel-L (RYONCIL) treatment for paediatric patients with steroid-refractory acute graft versus host disease (SR-aGVHD). The regulator has asked Mesoblast to undertake at least one more randomised, controlled study in adults and/or children. This is to provide further evidence of the effectiveness of remestemcel-L for SR-aGVHD. The company was also hit with a class action from disgruntled shareholders.
Flight Centre Travel Group Ltd (ASX: FLT)
The Flight Centre share price was a poor performer and dropped 20.5% in October. This sizeable decline appears to have been driven by a broker note out of Credit Suisse and escalating COVID-19 cases globally. In respect to the note, Credit Suisse downgraded the travel agency’s shares to a neutral rating with a $15.31 price target after pushing back its travel bookings recovery forecast by six months. This was to reflect a surge in COVID-19 cases in the northern hemisphere.
Regis Resources Limited (ASX: RRL)
The Regis Resources share price was out of form and sank 17.8% lower last month. Investors were selling this gold miner’s shares following a pullback in the price of the precious metal and an underwhelming quarterly update. The latter led to analysts at Macquarie reaffirming their underperform rating and slashing the price target on its shares down to $4.50. And while the Regis share price has since dropped below this target price, Macquarie has warned that the second quarter could also be weak.
Forget what just happened. We think this stock could be Australia’s next MONSTER IPO…
One little-known Australian IPO has doubled in value since January, and renowned Australian Moonshot stock picker Anirban Mahanti sees a potential millionaire-maker in waiting…
Because ‘Doc’ Mahanti believes this fast-growing company has all the hallmarks of genuine Moonshot potential, forget ‘buy now pay later’, this stock could be the next hot stock on the ASX.
See how you can find out the name of this stock
Returns as of 6th October 2020
More reading
- Is it time to buy ASX gold shares?
- These were the best performing shares on the ASX 200 in October
- 5 things to watch on the ASX 200 next week
- How La Nina will create unexpected ASX stock winners and losers
- These were the worst performing shares on the ASX 200 last week
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Flight Centre Travel Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The post These were the worst performing shares on the ASX 200 in October appeared first on Motley Fool Australia.
from Motley Fool Australia https://ift.tt/3jFuXq4
Leave a Reply